DE69712182T2 - Peptide und ihre verwendung in der therapie von krankheiten des zöliakie-formenkreises - Google Patents

Peptide und ihre verwendung in der therapie von krankheiten des zöliakie-formenkreises

Info

Publication number
DE69712182T2
DE69712182T2 DE69712182T DE69712182T DE69712182T2 DE 69712182 T2 DE69712182 T2 DE 69712182T2 DE 69712182 T DE69712182 T DE 69712182T DE 69712182 T DE69712182 T DE 69712182T DE 69712182 T2 DE69712182 T2 DE 69712182T2
Authority
DE
Germany
Prior art keywords
celiac
celebia
peptides
therapy
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69712182T
Other languages
English (en)
Other versions
DE69712182D1 (de
Inventor
Vincenzi Massimo De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Superiore di Sanita ISS
Original Assignee
Istituto Superiore di Sanita ISS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Superiore di Sanita ISS filed Critical Istituto Superiore di Sanita ISS
Publication of DE69712182D1 publication Critical patent/DE69712182D1/de
Application granted granted Critical
Publication of DE69712182T2 publication Critical patent/DE69712182T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69712182T 1996-01-26 1997-01-16 Peptide und ihre verwendung in der therapie von krankheiten des zöliakie-formenkreises Expired - Lifetime DE69712182T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96RM000052A IT1283899B1 (it) 1996-01-26 1996-01-26 Peptidi e loro usi nella terapia della malattia celiaca
PCT/IT1997/000007 WO1997027217A1 (en) 1996-01-26 1997-01-16 Peptides and uses thereof for therapy of celiac diseases

Publications (2)

Publication Number Publication Date
DE69712182D1 DE69712182D1 (de) 2002-05-29
DE69712182T2 true DE69712182T2 (de) 2002-11-21

Family

ID=11403826

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69712182T Expired - Lifetime DE69712182T2 (de) 1996-01-26 1997-01-16 Peptide und ihre verwendung in der therapie von krankheiten des zöliakie-formenkreises

Country Status (6)

Country Link
EP (1) EP0876399B1 (de)
AT (1) ATE216707T1 (de)
AU (1) AU1318797A (de)
DE (1) DE69712182T2 (de)
IT (1) IT1283899B1 (de)
WO (1) WO1997027217A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6348495B1 (en) 1996-06-06 2002-02-19 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Method for treating celiac disease
WO2007105024A1 (en) * 2006-03-15 2007-09-20 Isocell Pharma S.A. Pharmaceutical compositions comprising sods and prolamine based peptide fragments
FR2925328B1 (fr) * 2007-12-21 2011-08-12 Vincience Utilisation d'un hydrolysat de kamut en tant que principe actif activateur de la synthese des aquaporines
KR20140045439A (ko) * 2011-05-26 2014-04-16 미치오 타니 자폐증 개선제 및 자폐증 개선용 차
ITRM20110487A1 (it) 2011-09-19 2013-03-20 Consiglio Per La Ricerca E La Speri Mentazione In Peptidi aventi effetto protettivo nei confronti della attività infiammatoria del peptide 31-43 della a-gliadina nella malattia celiaca.
ES2402286B1 (es) 2011-09-29 2014-03-04 Universidad De Valladolid Péptido inmunogénico del gluten y sus aplicaciones.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826765A (en) * 1986-10-24 1989-05-02 The United States Of America As Represented By The Secretary Of The Agriculture Yeast strains genetically engineered to produce wheat gluten proteins
WO1994026774A1 (en) * 1993-05-19 1994-11-24 Cytel Corporation Novel treatments for allergic diseases

Also Published As

Publication number Publication date
WO1997027217A1 (en) 1997-07-31
AU1318797A (en) 1997-08-20
ITRM960052A1 (it) 1997-07-26
EP0876399B1 (de) 2002-04-24
IT1283899B1 (it) 1998-05-07
ATE216707T1 (de) 2002-05-15
DE69712182D1 (de) 2002-05-29
EP0876399A1 (de) 1998-11-11
ITRM960052A0 (it) 1996-01-26

Similar Documents

Publication Publication Date Title
DE69326064D1 (de) Peptide des menschlichen Proteins P53 zum Gebrauch in menschlichen-zytotoxischen-T-Zell-Antwort-induzierenden Kompositionen sowie menschliche P53-Protein-spezifische T-Lymphocyten
DK1521774T3 (da) Trunkerede Tau-proteiner
ATE198050T1 (de) Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia
DE69434926D1 (de) Menschlicher gewebsinhibitor von metalloproteinase-4
DE69838544D1 (de) Isolierung von gewebspezifischen peptidliganden und ihre verwendung zur ausrichtung von pharmazeutika auf zielorgane
DE69526216D1 (de) Antifungaleverfahren und mitteln
ATE396205T1 (de) Die verwendung von peptiden von il-2 und peptid- derivaten als therapeutische wirkstoffe
DE69534180D1 (de) Promotor der tie rezeptor protein kinase
ATE191922T1 (de) Feststellung der wechselwirkungsstelle zwischen p21-waf und pcna und deren therapeutischen verwendungen
BR9607628A (pt) Mólecula proteinácea biologicamente isolada, molécula recombinante, fragmento de peptìdeo, molécula de ácido nucleico, composição farmacêutica, e, processos para preparar uma molécula recombinante e para induzir a proliferação astroglial em um mamìfero
DE69835680D1 (de) Therapeutische verwendung von smr1 protein und seinen aktiven derivaten
FI940375A (fi) Peptidit, joilla on elimiä suojaavaa vaikutusta, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa
HUP9900506A2 (hu) Protrombinszármazékok
ATE197403T1 (de) Methoden zur detektion und behandlung von individuen mit abnormalen hla-a2/tyrosinase- peptidantigenen exprimierenden zellen
DE69725882D1 (de) Adenovirus e4 proteine für induktion von zelltod
DE69712182T2 (de) Peptide und ihre verwendung in der therapie von krankheiten des zöliakie-formenkreises
ATE251886T1 (de) Verwendunf von apoe zum binden von tau und map2c proteinen und zur behandlung von alzheimer's krankheit
AU2579995A (en) Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
EA199901061A1 (ru) Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии
RU95120588A (ru) Циклогексапептиды, их смеси, способ их получения и применения
ATE300554T1 (de) Bindegewebe-wachstumsfaktor 3.
ATE30238T1 (de) N-acylderivate von peptiden, ihre herstellung und verwendung bei der bekaempfung von krankheiten und mittel dafuer.
KR100194283B1 (ko) B형 간염 바이러스에 대한 인체 면역조절기능을 가진 x 단백질 유래의 펩타이드
TH31634A (th) เพพไทด์ชนิดใหม่ที่เหมาะสมสำหรับใช้ในการบำบัดรักษาที่กดภูมิคุ้มกันที่มีความจำเพาะต่อแอนติเจน

Legal Events

Date Code Title Description
8364 No opposition during term of opposition